📰 Recursion Pharmaceuticals News
Page 24 - Recursion Pharmaceuticals News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Recursion Pharmaceuticals. Real-time updates on events, politics, business and more.
September 11, 2023
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report)’s stock price shot up 5.6% during mid-day trading on Monday . The company traded as high as $8.55 and last traded at $8.51. 851,636 shares changed hands during trading, a decline of 73% from the average session volume of 3,192,473 shares. The stock had previously closed at […]
September 9, 2023
Needham & Company LLC reiterated their buy rating on shares of Recursion Pharmaceuticals (NASDAQ:RXRX – Free Report) in a research note published on Tuesday, Benzinga reports. They currently have a $17.00 price objective on the stock. Other analysts have also issued research reports about the company. KeyCorp boosted their price target on Recursion Pharmaceuticals from […]
September 7, 2023
Wall Street analysts foresee these pre-commercial-stage drugmakers rocketing higher over the next 12 months.
September 6, 2023
Wall Street analysts foresee these pre-commercial-stage drugmakers rocketing higher over the next 12 months.
September 1, 2023
Dublin, Sept. 01, 2023 (GLOBE NEWSWIRE) -- The "Bayer AG - Digital Transformation Strategies" report has been added to ResearchAndMarkets.com's...
September 1, 2023
Recursion Pharmaceuticals uses machine learning to develop drugs with Bayer and Genentech. CEO Chris Gibson thinks proceeding with that work outweighs any risks a moratorium might prevent.
August 31, 2023
/PRNewswire/ -- Ceribell, Inc.®, the pioneer in AI-powered point-of-care neurodiagnostics, today announced Louisa Daniels has joined the medical device company...
August 30, 2023
The famous growth investor has been making some interesting stock moves lately.
August 30, 2023
Operator: Good afternoon, and welcome to the Third Quarter Fiscal 2023 Hewlett Packard Enterprise Earnings Conference Call. My name is Gary, and Ill be your conference moderator for todays call.
August 29, 2023
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) COO Tina Marriott Larson sold 3,000 shares of the company’s stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $8.66, for a total value of $25,980.00. Following the sale, the chief operating officer now directly owns 418,782 […]